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This paper describes the generation of genetically engineered bioluminescent magnetotactic bacteria (BL-MTB) and
their integration into a microfluidic analytical device to create a portable toxicity detection system.
Magnetospirillum gryphiswaldense strain MSR-1 was bioengineered to constitutively express a red-emitting click
beetle luciferase whose bioluminescent signal is directly proportional to bacterial viability. The magnetic properties
of these bacteria have been exploited as “natural actuators” to transfer the cells in the chip from the reaction to
the detection area, optimizing the chip’s analytical performance. A robust and cost-effective biosensor for the eval-
uation of sample toxicity, named MAGNETOX, based on lens-free contact imaging detection, has been developed.
A microfluidic chip has been fabricated using multilayered black and transparent polydimethyl siloxane (PDMS) in
which BL-MTB are incubated for 30 min with the sample, then moved by microfluidics, trapped, and concentrated
in detection chambers by an array of neodymium–iron–boron magnets. The chip is placed in contact with a cooled
CCD via a fiber optic taper to perform quantitative bioluminescence imaging after addition of luciferin substrate. A
model toxic compound (dimethyl sulfoxide, DMSO) and a bile acid (taurochenodeoxycholic acid, TCDCA) were
used to investigate the analytical performance of the MAGNETOX. Incubation with DMSO and TCDCA drastically
reduces the bioluminescent signal in a dose-related manner. The generation of bacteria that are both magnetic
and bioluminescent combines the advantages of easy 2D cell handling with ultra sensitive detection, offering
undoubted potential to develop cell-based biosensors integrated into microfluidic chips.Introduction
The increasing demand for robust and cost-effective portable
analytical devices for on-site environmental toxicity screening
has prompted the development of miniaturized whole-cell
biosensors which are able to provide information about
potential in vivo toxicity, thus predicting risks for human and
animal health.1 Advances in molecular biology techniques
offer the opportunity to enable cells to express specific recog-
nition elements such as receptors or regulatory proteins
which trigger intracellular signaling events as a result of a
specific interaction with target analyte(s). Reporter gene tech-
nology is based on a cascade of signaling events whichultimately result in the expression of a reporter protein, such as
green fluorescent protein (GFP) or luciferase, whose expression
can be measured by fluorescence or bioluminescence (BL).2
Thanks to the high signal/noise ratio and no need for an
external light source or special sample geometry, measure-
ment of BL represents one of the most powerful detection
strategies for miniaturized devices.3 Besides, the availability
of several luciferases with different BL emission properties
allows development of cell-based BL assays in multiplex for-
mats or use of an internal control to correct the analytical
signal according to cell viability.4 Whole-cell biosensors are
suitable for implementation in miniaturized and/or micro-
fluidic devices, with the advantages of low sample and reagent
consumption, portability, and short analysis time. Several
examples of detection of different classes of analytes, ranging
from heavy metals to endocrine disruptors have been
reported.5,6 Nonetheless, the majority of previously reported
devices lack adequate analytical performance for real-life
applications, and have thus failed to reach the market.7,8 To
increase the robustness of such devices, several cell immobi-
lization strategies have been investigated, aiming to keep the2013, 13, 4881–4889 | 4881


















View Article Onlinecells alive and responsive to the target analyte. However,
analyte and/or reagent (e.g., oxygen, BL substrates…) diffusion
through the immobilization matrix may result in prolonged
analysis time and reproducibility issues.
A promising strategy to improve the sensitivity of BL-based
devices is to move the cells between different areas of the chip
which are appointed to carry out specific functions such as:
incubation of the sample, reagent(s) addition, washing and
detection. To this end the exploitation of magnetotactic bacte-
ria (MTB) magnetism as a “natural actuator” could represent
a valuable approach.
MTB have the innate ability to produce magnetosomes (or
bacterial magnetic nanoparticles, BacMPs), i.e. nanoparticles of
magnetite (Fe3O4) or greigite (Fe3S4) enveloped in a 3–4 nm
thick lipid membrane, which are aligned in a well-ordered
chain to achieve the maximum magnetic moment. Owing to
the presence of magnetosomes, MTB orient and migrate along
geomagnetic field lines. In past years, extensive research has
been focused on the elucidation of the mechanisms regulating
magnetosome biosynthesis and on the optimization of culture
techniques for the production and purification of BacMPs.9,10
Two major strategies can be envisaged to exploit MTB for
bioanalytical applications: (i) the use of genetically engineered
MTB as living biosensors, and (ii) the use of BacMPs as an
alternative to chemically synthesized magnetic nanoparticles
(MNPs). So far, the latter has been explored more extensively.
Thanks to their size, ranging from 30 to 120 nm,11 and their
biocompatibility, due to the presence of a surrounding lipid
bilayer membrane, BacMPs are highly advantageous for devel-
oping several kinds of biosensors, and more generally for
binding assays12,13 and drug delivery systems.14
Although significant advances in genomic studies of MTB
have been reported,15 the genetic engineering of MTB neces-
sary to obtain magnetic bioluminescent whole-cell biosensors
(BL-MTB) has not been accomplished. In addition, a minia-
turized device integrating BL-MTB and a light detector has
not been reported in the scientific literature.
As a first proof of concept of this new approach,
M. gryphiswaldense MSR-1 strain was genetically engineered to
constitutively express a red-emitting luciferase. A microfluidic
chip prototype has been fabricated using multilayered polydi-
methylsiloxane (PDMS) constituted of three diamond-shaped
incubation chambers connected with detection areas. After
incubation with the sample, bacteria can be magnetically
trapped and concentrated in the detection areas which are
placed in contact with a charge-coupled device (CCD) sensor
via a fiber optic taper to maintain adequate spatial resolution.
Quantitative BL imaging is performed over a period of a few
minutes, upon substrate addition (D-luciferin). This prototype
was used as a rapid and sensitive biosensor for the evalua-
tion of sample toxicity.
Results and discussion
In this study we genetically engineered magnetotactic bacteria
to obtain BL magnetic biosensors. Some so-called4882 | Lab Chip, 2013, 13, 4881–4889“magnetically labeled biosensors” have been previously
obtained by chemical functionalization of cells (mammalian
cell lines, yeast and bacteria) with synthetic MNPs.16,17 Indeed
this approach has some technical limitations requiring
functionalization steps that may create standardization prob-
lems; the cells divide during the incubation time and the
number of MNPs on each cell’s surface decreases, thus nega-
tively affecting the reproducibility of an assay relying on the
movement or trapping of biosensing cells within a micro-
fluidic chip via magnetic fields. Our strategy exploits the
intrinsic capability of magnetotactic bacteria, such as
Magnetospirillum gryphiswaldense, to produce a chain of mag-
netic nanoparticles (magnetosomes) within the cell which
confer the ability to orient and migrate along magnetic field
lines. The number and shape of the genetically encoded mag-
netic particles is strictly regulated by the bacterial genome.
When grown in microaerobic conditions the majority of
the cells are magnetic and retain magnetic properties
through cell divisions. For the purpose of microfluidic chip
integration we choose magnetotactic bacteria in order to have
a homogenous population of magnetic cells.
The biosensors were integrated into a newly designed
magnetic microfluidic chip, named MAGNETOX, which facili-
tates rapid, sensitive and direct toxicity screening without the
need for sample pre-treatment steps.
The use of a magnetic array to separate the biosensing cells
from the sample allows simultaneous removal of interferents
and concentration of the BL-MTB in front of the CCD device,
improving BL detection in terms of light output and sensitivity.Preparation and characterization of bioluminescent
magnetotactic bacteria
M. gryphiswaldense has been selected as the host strain
because it is well characterized and its genetic toolbox is
well developed.18
The M. gryphiswaldense strain MSR-1 was genetically
engineered to express the red-emitting click beetle luciferase
(CBR, λmax = 615 nm) under the control of the constitutive
PmamDC45 minimal promoter which ensures high expression
levels of heterologous proteins (unpublished data). To this
end, CBR luciferase, a mutant of a yellow-green luciferase from
Pyrophorus plagiophthalamus, was selected as the reporter
protein because of its thermostability, pH-insensitivity and
glow type emission.19
When expressed in bacterial cells, CBR has a much longer
half-life than the wild-type P. pyralis luciferase (5 h vs.
0.26 h).20 Since CBR requires endogenous bacterial ATP for
the chemical reaction, any change in light output truly
reflects alterations in the viability and metabolic state of the
cell. A shuttle vector containing the cDNA encoding for CBR
under the regulation of a constitutive promoter was used to
transform an E. coli donor strain and was transferred to
MSR-1 strain by conjugation.
The BL emission of the BL-MTB cells was investigated in
terms of kinetics and spectral emission properties to obtainThis journal is © The Royal Society of Chemistry 2013


















View Article Onlineinformation useful for the subsequent implementation of the
cells in the microfluidic chip. For this reason we measured
the BL signals emitted by intact living cells in 96-well
microplates after addition of the BL substrate D-luciferin at
pH 5.0. The BL-MTB emission kinetics showed that after
injection of the BL substrate the signal reached a peak within
a few seconds followed by rapid decay and stabilization at a
signal corresponding to about 50% of the maximum BL emis-
sion (see Fig. 1(a)). Therefore a suitable temporal window
from 5 to 15 min was identified for the BL measurements.
This glow-type emission is particularly interesting for imag-
ing applications since it allows integration of the BL signal
over several minutes, thus increasing sensitivity. The BL
emission spectrum showed a λmax at 615 nm with a half
bandwidth of 53 nm (see Fig. 1(b)), consistent with CBR
expression in other bacterial systems such as E. coli strains
(data not shown).
As known from other proteins previously expressed in
MSR, cytoplasmic expression of the luciferase enzyme is not
likely to influence magnetosome formation. This was con-
firmed by transmission electron microscope (TEM) character-
ization which revealed that the magnetosome number and
morphology in BL-MTB was indistinguishable from those of
MSR-1 wild-type strain (see Fig. 1(d)).Fig. 1 Characterization of the bioluminescent magnetotactic bacteria BL-MTB. (a) No
(c) Time dependent expression of the CBR luciferase and cell magnetism (Cmag) of the grow
with a Morgagni 268 at 80 kV. Inset shows a magnified image of the magnetosome chai
This journal is © The Royal Society of Chemistry 2013Investigation of the time dependent luciferase expression
and cell magnetism led to 3 day-old cultures being selected
for inclusion in the MAGNETOX biosensor. Fig. 1(c) shows
both the BL signal and the cell magnetism (Cmag) of BL-MTB
cultured in a medium containing Fe(III) citrate. Luciferase BL
reached a maximum intensity at 72 h after inoculation, when
micro-aerobic conditions prevailed and cell magnetism was
1.40 ± 5% (corresponding to 90% of the maximum Cmag
obtained after 6 days incubation). Magnetic properties were
also macroscopically confirmed by moving the BL-MTB with
a permanent magnet (see movie M1†).Design and fabrication of the MAGNETOX microfluidic chip
Exploiting multilayer PDMS casting, a microfluidic chip
comprising incubation and detection chambers, in which
BL-MTB can be loaded and trapped into specific positions for
analysis, has been fabricated. The chip comprises three, 60 μl
volume, diamond-shaped incubation chambers, each of them
connected to two detection areas to which the BL-MTB
can be navigated via a microfluidic system, then trapped
and accumulated using permanent magnets (see Fig. 2). Sub-
sequently the BL substrate can be delivered to the 6 detection
chambers allowing simultaneous imaging. Lens-free BLrmalized BL emission kinetics. (b) Normalized emission spectrum (λmax = 615 nm).
ing BL-MTB cultures. (d) TEM micrographs of MSR-1 expressing CBR luciferase taken
n.
Lab Chip, 2013, 13, 4881–4889 | 4883
Fig. 2 The MAGNETOX biosensor. (a) Schematic representation of the microfluidic chip comprising three diamond-shape incubation chambers and clear-bottom detection
areas. (b) Main components of the MAGNETOX biosensor: the microfluidic chip, the magnet array, the portable CCD camera with a fiber optic taper for lens-free BL imaging,
and a lid for shielding against ambient light.


















View Article Onlineimaging was performed using a CCD camera interfaced with
a fiber optic taper to maintain adequate sample resolution.21
This prototype configuration was designed to concentrate the
cells in a reduced volume, thus improving light collection
from the detection chambers. This strategy will be pursued to
further miniaturize the MAGNETOX chip and increase the
number of detection areas.
Another feature of the MAGNETOX is that, after analysis,
the cells are washed out of the chip so that it can be re-used.
Since incubation of cells with the analyte lasts only 30 min
no sterility is required and the chip can simply be washed
with 70% ethanol before reuse. This makes the device suit-
able for applications in low-resource settings.
As we previously reported, CCD contact lens-less imaging
does not require any optical system, thus simplifying the fabri-
cation of compact and miniaturized analytical devices.22 In addi-
tion lens-less imaging achieves a higher level of detection by
taking advantage of the light collection efficiency of the system.
The Sony ICX285 monochrome CCD sensor has been
selected since it has a quantum efficiency higher than 50% in
the range of 420–680 nm which covers the whole emission of
the CBR reporter. A fiber optic mosaic taper which transmits
the emitted light directly to the CCD sensor was used to
increase the sensing surface by 2.3 times compared to the
actual size of the CCD sensor (i.e., from 9.0 × 6.7 mm2 to
20.7 × 15.4 mm2), whilst still maintaining good resolution. A
double Peltier cooling system reduced the thermal noise of
the CCD, thus improving the signal/noise ratio and a lid
provided shielding against ambient light.4884 | Lab Chip, 2013, 13, 4881–4889The most significant improvements made to the device
are: i) the implementation of a straightforward strategy to
cast black and transparent PDMS; ii) the integration of a
magnet array into the chip; iii) the design and fabrication of
a microfluidics platform optimized for magnetic biosensors.
Although the use of black PDMS (a suspension of charcoal
in PDMS) to fabricate microfluidic devices has been already
reported elsewhere,23 to the best of our knowledge the pres-
ent work represents the first proof of concept for a black
PDMS microfluidic chip that includes detection chambers
with transparent bottoms for BL imaging detection. In addi-
tion this approach may have a more general application for
optical detection.
We first investigated the ability of neodymium–iron–
boron (NdFeB) magnets to rapidly and efficiently trap
BL-MTB within the chip. Fig. 3(a) shows BL images of the
MAGNETOX chip obtained after D-luciferin addition. At first,
the signal is homogeneously distributed in the incubation
chambers. As expected, after magnetic trapping, the BL
signal is mostly concentrated in the detection chambers
(approximately 85% of total light emission) (see Fig. 3(b)).
Weak signals still appear along the microfluidic channels,
indicating that the magnetic trapping could be further opti-
mized to improve reproducibility. The prototype was pur-
posely designed to disregard the signal emitted by BL-MTB
in the microfluidic channels or in the incubation chambers.
In fact the background signal of the non-trapped cells does
not interfere with the CCD detection since the channels are
made from black PDMS.This journal is © The Royal Society of Chemistry 2013
Fig. 3 BL images of BL-MTB inside the incubation chambers (a) and after cell move-
ment and magnetic trapping in the detection chambers (b). The MAGNETOX chip
was imaged from the top using a Night Owl LB 981 luminograph (EG&G Berthold,
Bad Wildbad, Germany) with 5 min integration. A 3D surface plot visualization was
obtained using ImageJ software.


















View Article OnlineIn addition, thanks to the reflective surface of the mag-
nets, BL emitted towards the opposite side of the sensor can
also be detected, thus increasing the sensitivity of the analy-
sis. The use of a reflecting surface increases the light signal
by approximately 30% compared to that obtained with black
tape covered magnets (data not shown).Fig. 4 (a) BL images obtained with the MAGNETOX and 3D surface plot
visualization using ImageJ software. Circular ROI were selected and the BL signals
were quantified. (b) Normalized toxicity curves for DMSO (30 min incubation)
obtained with the BL-MTB in the microwell cartridge (dashed line) and with the
MAGNETOX chip (solid line).Evaluation of sample toxicity with the MAGNETOX platform
The feasibility of the MAGNETOX platform as a general toxic-
ity biosensor was assessed using standard solutions of DMSO,
as model toxic compound and TCDCA, a detergent bile acid
that causes structural and dynamic effects in membranes.
The toxic effect of DMSO is mainly due to its activity in the
cell membrane,24 which affects cell metabolism and viability.
The alteration of cell energy systems dramatically alters intra-
cellular ATP levels, which can be monitored with an
ATP-dependent luciferase. Therefore only metabolically active
cells are able to provide the bioluminescent signal, which
reflects their viability.
Concentration-response curves for DMSO were obtained
and compared to those obtained for BL-MTB in a minia-
turized 6-well cartridge (see Fig. S1(a)†). This microwell cart-
ridge, containing 6 wells of 60 μL volume each, was
purposely designed for integration in the same portable
device. This allowed the actual advantage of concentrating
BL-MTB via microfluidics and adding the BL substrate after
a washing step to be assessed in comparison to a conven-
tional microwell format using the same CCD detector. The
BL recombinant cells were incubated for 30 min at room
temperature with different concentrations of toxic com-
pounds inside the MAGNETOX chip or inside the microwells.
For the MAGNETOX assay, after incubation the cells were
moved towards the detection chamber, and trapped by the
magnetic array. Upon addition of the D-luciferin substrate,
images were acquired with the CCD detector and analyzed toThis journal is © The Royal Society of Chemistry 2013quantify BL emission (see Fig. 4(a)). Fig. 4(b) shows that the
BL signal is strongly affected by DMSO with an LC50 of
7.5% v/v DMSO obtained in both configurations. The two
curves showed a similar sensitivity with slight differences at
low DMSO concentrations (e.g., in the MAGNETOX a 2.5% v/v
DMSO produces a signal of 75 ± 12% whereas 85 ± 5% is
recorded in the microwell configuration) while at DMSO con-
centrations higher than 40% v/v complete cell death is
observed in both the configurations.
We then used the bile acid TCDCA (0.001–10 mM). An
increasing toxic effect was observed (see Fig. 5) while
approaching the TCDCA critical micelle concentration (CMC
3 mM).25 Micelles can modify the membrane constituents,
thus resulting in a change in physicochemical properties
causing adverse effects on cell viability.26,27Lab Chip, 2013, 13, 4881–4889 | 4885
Fig. 5 Toxicity curve for TCDCA (0.001–10 mM) obtained with the MAGNETOX
chip. BL images corresponding to each duplicate are shown in the inset. The
BL-MTB cells are incubated for 30 min at room temperature with increasing concen-
trations of TCDCA inside the MAGNETOX chip. After incubation the cells are moved
towards the detection chamber, and trapped by applying the magnetic array. Upon
addition of the D-luciferin substrate, images are acquired with the CCD sensor and
analyzed to quantify BL emission.


















View Article OnlineThe response measured by the MAGNETOX assay was
quite reproducible with an intra-assay variability of 15% cal-
culated by considering the 6 detection chambers as replicates
and an inter-assay variability of 18% with four replicates. We
also compared the results with the closest widely recognized
assay, the Microtox® system, which measures the light output
of luminescent bacteria (Vibrio fischeri) after they have been
exposed to a sample. Using 1 h incubation with standard
solutions containing different concentrations of DMSO we
observed an LC50 of 8.3% v/v DMSO with the first toxic effects
appearing at 2.5% v/v DMSO (BL signal 81 ± 9%) and com-
plete cell death at DMSO concentrations higher than 40% v/v,
(see Fig. S2†), these results are consistent with the
MAGNETOX assay.
These preliminary results show that it is possible to exploit
magnetic concentration to increase light output and reduce
assay volume. Despite this, the reproducibility of the
MAGNETOX assay could be improved by optimizing the
microfluidic chip design and fabrication. These results sup-
port the use of BL-MTB as a powerful tool suitable for
microfluidic (bio)sensors.
In addition, the generation of BL-MTB with a codon-
optimized version of the luciferase integrated into the bacterial
chromosome would surely result in a more robust biosensor.
The use of a codon optimized luciferase coding sequence could
reduce the time required for its expression. Indeed MAGNETOX
assays performed using overnight and 36 h-old cultures resulted
in lower analytical performance (e.g., no significant biolumines-
cent signal at concentrations higher than 20% DMSO v/v and
an increased coefficient of variation (CV% = 20%)).4886 | Lab Chip, 2013, 13, 4881–4889To circumvent this limitation, lyophilized BL-MTB will be
obtained providing a ready-to-use suspension of organisms
for use in the chip. The implementation of BL-MTB in field-
deployable devices could be exploited for direct analysis of
environmental or clinical samples containing matrix compo-
nents, which may interfere with the BL detection but could
be easily removed from detection areas. As an alternative, a
microelectromagnetic pad actuator could be used to precisely
control the movement and positioning of BL-MTB within the
microfluidic chip and further miniaturize the system.
Experimental
Chemicals and reagents
All chemicals used for cell culture media preparation and
toxic compounds were purchased from Sigma (St. Louis,
Missouri, USA). The enzymes required for cloning were from
Fermentas (Vilnius, Lithuania). The kits for plasmid extrac-
tion and purification were from Qiagen (Hilden, Germany).
Sylgard 184 (Dow Corning, USA) was used to create the
PDMS chip. D-Luciferin solution, 1 mM at pH 5.0, was pre-
pared by dissolving 28.3 mg D-luciferin sodium salt
(Synchem, Kassel, Germany) in 35 mL of 0.1 M citric
acid and 65 mL of 0.1 M trisodium citrate solution.
Taurochenodeoxycholic acid sodium salt (TCDCA) dilutions
were prepared in FSM medium.
Organism and growth conditions
The M. gryphiswaldense strain (MSR-1 R3/S1; Rifr Smr sponta-
neous mutant)28 was cultured at 28 °C in 10 mL hungate
tubes (GPE Scientific UK) in microaerobic conditions (1% O2
in the headspace). The oxygen concentration in the gas phase
was reduced to less than 1% O2 by repeated flushing with N2.
An MSR-1 medium with 50 μM Fe(III) citrate was used as
described by Heyen and Schüler.29
Obtainment of bioluminescent magnetotactic bacteria
(BL-MTB) and characterization of emission properties
M. gryphiswaldense strain was genetically engineered to consti-
tutively express the red-emitting click beetle luciferase (CBR,
λmax = 615 nm). Briefly, the cDNA encoding for CBR was PCR
amplified from the vector pCBRbasic (Promega, WI, USA) using
the primers CBR Fw AGTGGATCCTTACTAACCGCCGGCCTT
and CBR Rev CAGCATATGGTAAAGCGTGAGAAAAAT, adding
BamHI and NdeI restriction sites, shown in bold. These
restriction enzymes were then used to digest and insert the
luciferases into the pAP150 vector under the control of the
PmamDC45 constitutive promoter. The resulting vector pAP150-
CBR was used to transform the E. coli donor strain (BW29427
[thrB1004 pro thi rpsL hsdS lacZ-M15 RP4-1360-(araBAD)567-
dapA1341::(erm-pir-)] (K. Datsenko and B. L. Wanner,
unpublished) via heat shock30 and transferred to the MSR
strain by conjugation.28 The obtained strain (MSR-CBR) was
routinely grown microaerobically at 28 °C in a selective MSR
medium containing 5 μg mL−1 kanamycin. MSR-CBRThis journal is © The Royal Society of Chemistry 2013


















View Article Onlineemission kinetics and bioluminescence emission spectra were
obtained in a 96-well plate using 100 μL overnight liquid cul-
tures; the BL signal was acquired for 10 minutes (300 ms inte-
gration time) with a Varioskan Flash spectral scanning
multimode reader (Thermo Scientific, Whaltham, MA, USA)
after automatic injection of 100 μL D-luciferin 1 mM, pH 5.0.
Bandwidths (nm) of the emission spectra were measured at
50 and 20% of the intensity at the maximum wavelength. Data
were analyzed with GraphPad Prism v5.02 (Software, Inc., San
Diego, CA, USA). All light measurements were performed
in triplicate.
TEM micrographs of MSR-1 expressing CBR luciferase
were taken at 18k × and 71k × with a Morgagni 268 at 80 kV.
Evaluation of luciferase time dependence and magnetic
orientation
The magnetic orientation (Cmag) of the MSR-CBR cells was
evaluated spectrophotometrically using the optical density at
565 nm as previously described.31 Briefly, at given time inter-
vals, cell suspensions of 1.0 mL were withdrawn from the cul-
ture for Cmag measurement. Cell density was set to an OD of
0.1 and an external magnetic field was applied to align the
cells at different angles towards the light beam of the spec-
trometer. This results in maximum and minimum light
extinction and the ratio of these correlates with the average
number of magnetosomes per cell. This method is used to
semi-quantitatively assess the magnetism of a culture (non-
magnetic cells have a Cmag value of 0).
Design and fabrication of the MAGNETOX microfluidic chip
The microfluidic chip fabrication process is based on multi-
ple layer casting of black and transparent PDMS on a home-
made master mold.
Transparent PDMS was prepared using a monomer curing
agent in a weight ratio of 5 : 1, 25 mg mL−1 of activated char-
coal powder was added to obtain black PDMS. The solutions
were then centrifuged at 4000 rpm for 10 min to remove bub-
bles and stored at −20 °C until use.
Black PDMS was first poured in to fill up to the edge of
the relief structures on the mask, which creates the diamond-
shaped chambers (7.0 × 14.0 mm diagonals, height 1.5 mm),
the microfluidics channels (1 mm width) and detection areas
(3 mm diameter, height 1.5 mm). To avoid mixing with trans-
parent PDMS, black PDMS was allowed to harden for 1 h at
60 °C; then a thin layer of transparent PDMS was poured on
top of the black PDMS layer, to create the transparent bottom
of the wells, and allowed to harden for 2 h at 60 °C. During
the curing process the black and transparent PDMS layers
fuse together.
A separate layer of transparent PDMS was cast in a differ-
ent mold, comprising inlets and outlets, to create the top of
the chip and allowed to harden as previously described. The
two partially-cured PDMS layers were then removed from
their masks, superimposed and hardened overnight at 70 °C
to obtain the final chip (see Fig. 2(a)).This journal is © The Royal Society of Chemistry 2013An array of neodymium–iron–boron circular disc magnets
(NdFeB; NeoDeltaMagnet NE32, 3 mm diameter, L = 2 mm,
remanence 1170–1250 mT, IBS Magnet, Berlin, Germany) was
placed over the detection chambers of the PDMS chip.
The MAGNETOX device consists of the microfluidic
device connected to a CCD camera modified for lens-free
CL imaging detection. The CCD imaging detector was built
from a MZ-2PRO CCD camera (MagZero, Pordenone, Italy)
equipped with a Sony ICX285 monochrome CCD image sen-
sor (1360 × 1024 pixels, pixel size 6.45 × 6.45 μm2) and a
16 bit analog-to-digital (A/D) converter. To reduce thermal
noise, the CCD sensor was thermoelectrically cooled by a
double Peltier cell. A round fiber optic taper (25/11 mm size,
Edmund Optics, Barrington, NJ) was placed in contact with
the CCD sensor as previously described by our group.22 The
MAGNETOX is computer controlled via a USB 2.0 interface
using software (EZ Cap, v3.13) that facilitates data acquisi-
tion and parameter settings.
Design of a microwell cartridge
A custom made PDMS 6-well cartridge was produced using
black and transparent PDMS as previously described. The
mask for PDMS casting has been designed in order to
obtain an array of 2 × 3 wells of 4 mm diameter and 4.5 mm
deep each.
First, black PDMS was poured in to fill up to the edge
of the mask followed by addition of a thin (<200 μm) layer
of transparent PDMS to create the bottom of the wells
(see Fig. S1(b)†). After overnight incubation at 70 °C the
cartridge was carefully separated from the mask.
Toxicity evaluation using the MAGNETOX platform
Different concentrations of dimethyl sulfoxide (DMSO)
(in the range 2–50% v/v) and TCDCA (in the range 0.001–
10 mM) were used as model toxic compounds to evaluate the
feasibility of using BL magnetotactic bacteria as a toxicity bio-
sensor. All serial dilutions of compounds were performed
using FSM medium as a diluent.
Different experimental conditions were optimized to
improve the biosensor performance (e.g., incubation temper-
ature and time, volumes and ratio of cell suspension to
sample). Under optimized conditions, an analysis with the
MAGNETOX chip includes the following steps: i) 40 μL of
3 day-old liquid culture is driven into the chip by an air-
displacement pipette; ii) cells are incubated for 30 min at
room temperature with 20 μL of sample (medium is used as
blank); iv) cells are moved and concentrated in the detection
chambers by adding the array of permanent magnets; v) BL
imaging measurements after addition of 1 mM D-luciferin
pH 5.0. Images are acquired for 5 min and analyzed with
ImageJ software v.1.46 (National Institutes of Health,
Bethesda, MD). Images are recorded in the FITS (Flexible
Image Transport System) format. Regions of interest (ROIs)
corresponding to detection chambers are selected and light
emissions quantified as raw integrated densities.Lab Chip, 2013, 13, 4881–4889 | 4887


















View Article OnlineFor toxicity experiments, normalized BL signals (the BL
emission of the untreated control was set as 100%) were plot-
ted against toxic compound concentration. The lethal con-
centration (LC50) of each compound was calculated as the
concentration producing a 50% reduction in light.
All experiments were performed in duplicate and repeated
at least three times.
The toxic effects of DMSO and TCDCA solutions (in the
range 2–50% v/v and 0.001–10 mM, respectively) were also
assessed using a Microtox® assay with Vibrio fischeri.32 Differ-
ent exposure times were tested (10, 30 and 60 min at 25 °C)
in 96 microplate format using 90 μL of cell suspension and
10 μL of analyte or control (medium). The results were
analyzed as described for the MAGNETOX assay.
Conclusions
Here, for the first time, the use of bioengineered bioluminescent
magnetotactic bacteria in combination with microfabrication
technologies is reported for biosensing applications. The novel
concept of a black and transparent PDMS microfluidic chip
has been developed which could find broad use in the opto-
fluidic field. The chip has been integrated with a portable
CCD sensor for lens-less imaging detection of light signals
emitted by the BL magnetotactic bacteria used as biosen-
sing “living actuators”. Unlike other whole-cell biosensors,
BL-MTB can be easily moved and concentrated in specific
detection chambers, where the sample matrix is removed and
bacteria are washed, thus increasing the analytical signal and
performance of the system. The interaction of BL-MTB with
the analyte is facilitated in the detection chamber since this
interaction takes place in a dispersed suspension, resulting in
a shorter incubation time. In this regard, the MAGNETOX
assay faciliates rapid (30 min) measurement of sample toxic-
ity with the non negligible advantage of chip re-usability.
This is the first attempt to integrate bioengineered magne-
totactic bacteria into an analytical device and several optimiza-
tions regarding both the cell and the chip design will be
addressed. An array of electromagnets or a microelectro-
magnetic pad actuator will be included to better control the
BL-MTB within the chip by tuning the magnetic trapping or
continuously directing their swimming to the detection area.
Although many improvements are required before apply-
ing BL magnetic biosensors to real-life needs, we are confi-
dent that they represent the forerunner of a new concept in
whole-cell biosensing.
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